Product
CAZ/AVI + Aztreonam
1 clinical trial
1 indication
Clinical trial
Evaluation of Ceftazidime-avibactam Plus Aztreonam in Patients Infected by MBL-producing Enterobacterales and CRISPR/Cas9-based Strategy for Curing Drug-resistant GenesStatus: Recruiting, Estimated PCD: 2025-01-31